{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:16:31Z","timestamp":1768306591428,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"vor","delay-in-days":10110,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[1992]]},"DOI":"10.1254\/jjp.59.125","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T05:07:03Z","timestamp":1201151223000},"page":"125-128","source":"Crossref","is-referenced-by-count":18,"title":["Cholecystokinin Protects Cholinergic Neurons against Basal Forebrain Lesion"],"prefix":"10.1016","volume":"59","author":[{"given":"Kiminobu","family":"Sugaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1254\/jjp.59.125_bib1","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0306-4522(86)90142-9","article-title":"Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer\u2019s Disease","volume":"19","author":"Etienne","year":"1986","journal-title":"Neuroscience"},{"key":"10.1254\/jjp.59.125_bib2","series-title":"Animal Models of Dementia","first-page":"81","article-title":"Basal forebrain cholinergic neurons and Alzheimer\u2019s Disease","author":"Wenk","year":"1987"},{"key":"10.1254\/jjp.59.125_bib3","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.2890210","article-title":"Longterm neuropathological and neurochemical effects of nucleus basalis lesions in the rat","volume":"238","author":"Arendash","year":"1987","journal-title":"Science"},{"key":"10.1254\/jjp.59.125_bib4","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1471-4159.1987.tb02433.x","article-title":"Effects of nucleus basalis lesion on the muscarinic and nicotinic modulation of [3H]-acetylcholine release. The rat cerebral cortex","volume":"49","author":"Meyer","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1254\/jjp.59.125_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF01243353","article-title":"Physostigmine restores [3H]-acetylcholine efflux from Alzheimer brain slices to normal level","volume":"67","author":"Nilsson","year":"1986","journal-title":"J. Neural Transm."},{"key":"10.1254\/jjp.59.125_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0166-4328(84)90030-5","article-title":"Impairment in T-maze reinforced alternation performance following nucleus basalis magnocellularis lesions in rats","volume":"13","author":"Salamone","year":"1984","journal-title":"Behav. Brain. Res."},{"key":"10.1254\/jjp.59.125_bib7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0278-5846(91)90095-I","article-title":"Localization of cholecystokinin binding sites in canine brain using quantitative autoradiography","volume":"15","author":"Morency","year":"1991","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1254\/jjp.59.125_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jjp.48.1","article-title":"Autoradiographic demonstration of the antagonism of anthramycin and diazepam against cholecystokinin in the mouse brain using the [14C]-2-deoxyglucose method","volume":"48","author":"Sugaya","year":"1988","journal-title":"Japan. J. Pharmacol."},{"key":"10.1254\/jjp.59.125_bib9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1471-4159.1991.tb02009.x","article-title":"Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms","volume":"56","author":"Marshall","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1254\/jjp.59.125_bib10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0028-3908(84)90050-9","article-title":"Effect of cholecystokinin octapeptide and ceruletide on release of acetylcholine from cerebral cortex of the rat in vivo","volume":"23","author":"Magnani","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1254\/jjp.59.125_bib11","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1126\/science.3576201","article-title":"Modulation memory processing by cholecystokinin: Dependence on the vagus nerve","volume":"236","author":"Flood","year":"1987","journal-title":"Science"},{"key":"10.1254\/jjp.59.125_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0196-9781(91)90178-R","article-title":"Cholecystokinin blocks some effects of kainic acid in CA3 region of hippocampal slices","volume":"12","author":"Aitken","year":"1991","journal-title":"Peptides"},{"key":"10.1254\/jjp.59.125_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0304-3940(89)90370-4","article-title":"Stimulation of the nucleus basalis of Meynert increases cerebral cortical blood flow in rats","volume":"98","author":"Bisesold","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1254\/jjp.59.125_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0024-3205(81)90334-9","article-title":"Normal cortical concentration of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity in senile dementia of Alzheimer type","volume":"29","author":"Rossor","year":"1981","journal-title":"Life Sci."},{"key":"10.1254\/jjp.59.125_bib15","first-page":"134","article-title":"Therapeutic efficacy of cholecystokinin in neurolepitic-resistant schizophrenic subjects","volume":"19","author":"Nair","year":"1983","journal-title":"Psychopharmacol. Bull."}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819376802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819376802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T03:58:33Z","timestamp":1605671913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021519819376802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1992]]}},"alternative-id":["S0021519819376802"],"URL":"https:\/\/doi.org\/10.1254\/jjp.59.125","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[1992]]}}}